BofA cuts Constellation Brands to Underperform on weak beer demand

Bank of America downgraded Constellation Brands (STZ) to Underperform from Neutral and cut its price target to $150 from $182, citing persistent softness in beer consumption that creates significant risk to sales, profit margins, and valuation. Despite a 26% year-to-date stock decline, BofA believes STZ remains overvalued given revised beer depletion forecasts and a lower 2026 earnings outlook of $12.60, signaling potential further downside as the investment thesis shifts from growth to capital returns.

Analysis

Constellation Brands (STZ) faces a deteriorating outlook following a downgrade from Bank of America to 'Underperform' from 'Neutral', accompanied by a significant price target reduction to $150 from $182. The bank's rationale is rooted in persistently soft beer consumption, which it believes creates substantial risk to STZ's sales, profit margins, and valuation. Despite a 26% year-to-date decline in the stock, BofA contends it is not yet cheap, lowering its valuation multiple for the company to 11.5 times its fiscal 2026 earnings forecast, down from 13 times previously. This reassessment is underpinned by lowered fiscal 2026 earnings estimates of $12.60 per share and negative beer depletion forecasts, which project a 2.5% drop in Q2 and a 1.8% decline for the full fiscal year. The expected volume slowdown poses a direct threat to Constellation's industry-leading margins, which are highly dependent on growth, and signals a risky strategic shift from a growth narrative to a capital returns-focused story.

Key Decisions for Investors

• Investors should exercise caution and re-evaluate long positions in STZ, as the downgrade to 'Underperform' and the new $150 price target from Bank of America signal significant potential downside.
• Closely monitor key performance indicators such as beer depletion rates and profit margins in upcoming reports, as the negative forecast for a 1.8% full-year volume decline puts the company's primary profit driver at risk.
• Assess the company's strategic pivot from a growth narrative to one focused on capital returns, as this fundamental shift could lead to further valuation multiple compression if earnings growth continues to decelerate.